ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Ultrasound Therapy for Fibromyalgia and Lyme Disease

Curcumin: The All In One Solution, Part 2

What Are the Benefits of Vitamin K2?

Vitamin D deficiency + high fat diet = metabolic syndrome

Why You Should Take Your Apple Cider Vinegar at Night

Use Burdock Oil to Promote Healthy Hair Growth

AMA journal associates iron deficiency with hearing loss

Meet Your Weight Loss Goals

People with forms of early-onset Parkinson's disease may benefit from boosting niacin in diet, resea...

Lutein linked to preservation of crystallized intelligence

 
Print Page
Email Article

UAMS Reports Bone Loss From Oral Diabetes Drug

  [ 30 votes ]   [ Discuss This Article ]
www.ProHealth.com • October 9, 2003


LITTLE ROCK, Ark., Oct. 8 /PRNewswire/ -- Scientists at the University of Arkansas for Medical Sciences (UAMS) report in the journal Endocrinology that a widely used oral drug for type 2 diabetes may pose a significant risk of bone loss.

The researchers report that in a laboratory study the anti-diabetic compound rosiglitazone (known as Avandia), caused a significant decrease in total body bone mineral density, suggesting that Avandia therapy may pose a significant risk of adverse skeletal effects in humans.

"Avandia is an FDA-approved and clinically successful treatment for type 2 diabetes. Our findings suggest that doctors should watch the skeletons of patients who use this drug, especially older patients, because their patients may be at increased risk of bone loss over time," said lead researcher Beata Lecka-Czernik, Ph.D., a molecular and cell biologist.

An estimated 16 million Americans have type 2 diabetes, which results from insulin resistance, a condition in which the body does not properly use insulin, along with relative insulin deficiency. The disease typically develops in people over the age of 40. Rosiglitazone, a very effective anti-diabetic agent that reduces insulin resistance, has had federal approval since 1999.

The National Institute on Aging funded the research at UAMS with a five-year, $925,000 grant. Physiologists and endocrinologists Larry J. Suva, Ph.D., and Dana Gaddy, Ph.D., are co-investigators. Lecka-Czernik is a member of the Donald W. Reynolds Department of Geriatrics and Suva and Gaddy are members of the faculty of the Departments of Orthopaedic Surgery and Physiology and Biophysics, all in the UAMS College of Medicine. All three researchers are members of the Arkansas Cancer Research Center at UAMS. S. O. Rzonca and D. C. Montague, research assistants who conducted the experiment and technical analyses, are co-authors of the article in Endocrinology.

The UAMS scientists used micro-computed tomography to analyze the bones of healthy mice that received doses of rosiglitazone over seven weeks. The doses that mice received were the same doses mice received in earlier studies that demonstrated the compound's effectiveness for type 2 diabetes. The researchers next plan to test the effects of the drug on mice and rats with diabetes. Lecka-Czernik also has a grant for the follow-up study of $300,000
for three years from the American Diabetes Association.

A gift of $288,000 from the Roy and Christine Sturgis Charitable Trust in 2002 enabled UAMS to purchase the sophisticated bone analysis equipment used in the study.

The journal Endocrinology is published by The Endocrine Society. UAMS is the leading biomedical research institution in Arkansas and the home of the Donald W. Reynolds Center on Aging as well as the Donald W. Reynolds Department of Geriatrics.

SOURCE: University of Arkansas for Medical Sciences
Web Site: http://www.uams.edu



Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Ultra EPA  - Fish Oil FibroSleep™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Olea25 Olive Hydroxytyrosol Hits Astonishing 68,000+ ORAC Antioxidant Value Olea25 Olive Hydroxytyrosol Hits Astonishing 68,000+ ORAC Antioxidant Value
How I Found My Long-Lost Energy How I Found My Long-Lost Energy
Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel
Repair Damaged Mitochondria and Reduce Fatigue Up to 45% Repair Damaged Mitochondria and Reduce Fatigue Up to 45%
Soothe, Heal and Regulate Your Digestive System with Nutrient-Rich Aloe Vera Soothe, Heal and Regulate Your Digestive System with Nutrient-Rich Aloe Vera

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map